Anti-guinea pig primary antibodies recognize specific antigens in Cavia porcellus and support investigations of immune function, infectious diseases, vaccine responses, and inflammatory mechanisms. In guinea pig animal models, selected monoclonal antibodies have been used to manipulate immune cell populations and investigate their roles in disease progression. For example, a class-switched anti-guinea pig CD4 monoclonal antibody demonstrated effective in vivo depletion of CD4⁺ T cells, highlighting the importance of antibody isotype and effector properties in functional studies.
Key Features
-
Target specificity: Recognition of defined guinea pig antigens, including immune cell surface markers and cytokines, depending on the antibody.
-
Functional diversity: Depending on their experimentally validated properties, antibodies may support immune cell depletion, cytokine neutralization, or modulation of receptor activity.
-
Research applications: Studies of immunology, infectious diseases, inflammation, and vaccine responses in guinea pig models.
-
Application-specific validation: Target specificity, cross-reactivity, antibody isotype, dose, and biological activity should be evaluated for the intended in vivo protocol.
Common Research Applications
-
Investigating CD4⁺ T-cell function and immune regulation.
-
Studying cytokine-mediated responses, including interferon-gamma (IFN-γ) activity.
-
Evaluating immune responses during experimental infection and vaccination.
-
Examining the contribution of specific immune cell populations to disease mechanisms.

